Understanding the pathogenesis of coronary slow flow: Recent advances

Area of Science:

• Cardiology
• Vascular Medicine
• Pathophysiology

Background:

• Coronary slow flow (CSF) is characterized by delayed contrast agent transit in coronary arteries without significant stenosis.
• CSF significantly impacts patient quality of life due to recurrent chest pain.
• The underlying causes and mechanisms of CSF remain incompletely understood.

Purpose of the Study:

• To review recent research on the pathogenesis of coronary slow flow.
• To elucidate potential underlying mechanisms contributing to CSF.
• To identify therapeutic targets and future research directions for CSF.

Main Methods:

• Literature review of recent studies on coronary slow flow.
• Analysis of proposed etiological and pathogenetic factors.
• Synthesis of current understanding regarding CSF mechanisms.

Main Results:

• Current evidence suggests CSF may involve endothelial dysfunction, inflammation, microvascular abnormalities, subclinical atherosclerosis, hematological factors, and genetic predispositions.
• No single cause is definitively established, indicating a multifactorial etiology.
• Research is evolving to better understand the complex interplay of these factors.

Conclusions:

• Further investigation into the multifactorial pathogenesis of coronary slow flow is crucial.
• Elucidating these mechanisms will guide the development of targeted therapies.
• Future research should focus on identifying specific pathways for effective CSF management.